Drugs for Neglected Diseases initiative (DNDi), Switzerland

Time frame: 1 October 2022 - 30 September 2023


Position by research output Share

Global Switzerland
Overall 7107 180

Position by research output Share in subject areas

Global Switzerland
Biological sciences 4048 107
Chemistry 2402 48
Health sciences 4471 145


Overall research output

Count Share
Overall 2 0.03

Overall Count and Share for 'Drugs for Neglected Diseases initiative (DNDi)' based on time frame mentioned above, both domestically and internationally.

View all articles

Research outputs by subject area

Subject Count Share
Biological sciences 1 0.00
Chemistry 1 0.03
Health sciences 1 0.00

Note: Articles may be assigned to more than one subject area. Hover over the donut graph to view the Share for each subject.

Share output for the past 5 years

Compare with other institutions

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

  1. Track trends, summarise articles effortlessly.

  2. Spark serendipitous discoveries.

  3. Uncover collaboration opportunities.


International vs domestic collaboration by Share

Type Percentage
International (290 institutions) 98.0%
Domestic (10 institutions) 2.0%

Note: Hover over the graph to view the percentage of collaboration.

Top 5 domestic collaborators with Drugs for Neglected Diseases initiative (DNDi) by Share

Top 5 international collaborators with Drugs for Neglected Diseases initiative (DNDi) by Share

  • Advertisement

Latest supplement

Nature Index 2023 Climate and Conservation

Climate and conservation scientists are bringing real progress to the fight against global warming, despite political and funding obstacles. But greater support for strategic, multidisciplinary research is needed, if the world wants to improve its performance on the United Nations’ Sustainable Development Goals (SDGs).


Drugs for Neglected Diseases initiative (DNDi)